1.Intracoronary thrombosis treated with stent and abciximab in patient with membranous glomerulonephritis.
Sung Gyun AHN ; Seung Jea TAHK ; Jae Chul WHANG ; Sang Yong YOO ; Hyuk Jae JANG ; Lian Zhe XUN ; So Yeon CHOI ; Kyo Seung HWANG ; Myung Ho YOON ; Joon Han SHIN ; Byung Il CHOI ; Do Hun KIM
Korean Circulation Journal 2000;30(10):1307-1311
The association of nephrotic syndrome with a hypercoagulable state and vascular thrombosis is well recognized. In all adult series of nephrotics, venous thrombosis are much more common than arterial thrombosis, which has been mainly reported in children. Intracoronary thrombus is among the rarest arterial thromboses. We present a case of acute myocardial infarction in a 39-year-old women with nephrotic syndrome secondary to membranous glomeluronephritis, in which subsequent coronary angiography showed no evidence of atherosclerotic change and thrombotic occlusion in the left main coronary artery which was successfully treated with intracoronary stent and intravenous abciximab.
Adult
;
Child
;
Coronary Angiography
;
Coronary Vessels
;
Female
;
Glomerulonephritis, Membranous*
;
Humans
;
Myocardial Infarction
;
Nephrotic Syndrome
;
Stents*
;
Thrombosis*
;
Venous Thrombosis
2.A Case of Essential Thrombocythemia Complicated by Acute Myocardial Infarction.
Seung Woon RHA ; Sang Won PARK ; Sang Chil LEE ; Kyo Seung WHANG ; Jung Cheon AHN ; Woo Hyuk SONG ; Do Sun LIM ; Chang Gyu PARK ; Young Hoon KIM ; Hong Seog SEO ; Wan Joo SHIM ; Dong Joo OH ; Young Moo RO
Korean Circulation Journal 1998;28(1):97-102
Essential thrombocythemia, a subcategory of chronic myeloproliferative disorder, is characterized by absolute thrombocytosis due to excessive clonal proliferation of platelets, hyperaggregability of platelets and increased incidence of thrombosis and hemorrhage. Essential thrombocythemia may cause frequent vascular thrombosis, but it can be a rare cause of acute ischemic heart diseases such as acute myocardial infarction without atherosclerosis, unstable angina and angina pectoris. We report a case of essential thrombocythemia complicated by acute myocardial infarction. A patient with a previous history of vascular thrombotic complications (such as transient ischemic attack and deep vein thrombosis) was managed with 2.8 million units of intravenous urokinase, antiplatelet agent, ACEI, antianginal medications and hydroxyurea. There were clinically remarkable improvements and no further episodes of thrombotic ischemic vascular complications, including acute myocardial infarction.
Angina Pectoris
;
Angina, Unstable
;
Atherosclerosis
;
Hemorrhage
;
Humans
;
Hydroxyurea
;
Incidence
;
Ischemic Attack, Transient
;
Myeloproliferative Disorders
;
Myocardial Infarction*
;
Myocardial Ischemia
;
Thrombocythemia, Essential*
;
Thrombocytosis
;
Thrombosis
;
Urokinase-Type Plasminogen Activator
;
Veins
3.Effect of Double Bolus Urokinase on Thrombolysis in Acute Myocardial Infarction.
Seong Woon RHA ; Sang Won PARK ; Eun Mi LEE ; Kyo Seung WHANG ; Jung Chun AHN ; Woo Hyuk SONG ; Do Sun LIM ; Chang Gyu PARK ; Young Hoon KIM ; Hong Seog SEO ; Wan Joo SHIM ; Dong Joo OH ; Young Moo RO
Korean Circulation Journal 1997;27(11):1147-1159
BACKGROUND AND PURPOSE: Although thrombolytic strategies with streptokinase(STK) and tissue-type plasminogen activator(t-PA) in the treatment of acute myocardial infarction(AMI) have been studied in large-scale clinical trials in the western countries, such large-scale studies with urokinase(UK) are scanty. Even though UK is most commonly used thrombolytic agent for the treatment of AMI in Korea, there is no consensus on the dosage and the way of administration of UK in patients with AMI. Accordingly, a prospective clinical study was performed to evaluate the effects of thrombolytic strategies of intravenous double bolus method and standard double-infusion method with different dosage of UK in the treatment of AMI. SUBJECTS AND METHODS: Ninety there patients with AMI(male 75, female 18, age 57.5+/-10.8 years) were studied. The patients were divided into 3 groups according to dosage of UK and method of administration. Group I : 19 patients who received 1.5 million U of UK IV bolus, followed by 1.5 million U IV infusion for an hour(High Dose Group). Group II : 34 patients received 20,000U/kg body weight of UK IV bolus, followed by 20,000U/kg IV infusion for an hour(Double Dose Group). Group III : 40 patients received 1.5 million U of UK IV bolus and followed by 20,000U/kg IV bolus in 30 minutes with total dose of no more than 3 million U(Double Bolus Group). Coronary angiography(CAG) and left ventriculography(LVG) were performed 90 minutes after the administration of UK and post-AMI 7-10 days to investigate the patency of infarct-related artery(IRA) and LV function. Patency of IRA was graded according to the extent of flow of IRA. TIMI grade 0-1 was regarded as occluded, and grade 2-3 flow as patent. LV ejection fraction(EF) by echocardiography was measured on day 1, day 7-10 and 1 month after AMI. Indirect clinical parameters of thrombolysis were evaluated and were compared with CAG findings. RESULTS: 1) The 90 minutes IRA patency in Group III(Double bolus ; 79.0%) was higher than that in Group 1, but showed no statistically significant difference(High dose ; 61.5%, p=0.790). The 90 minutes IRA patency in Group III showed borderline significance with Group II(Double dose ; 57.1%, p=0.057). TIMI flow III in Group III(60.6%) was significantly higher than that in Group II(53.6%, p=0.0468) but showed no statistically significant difference with Group I(61.5%, p=0.158). 2) The EF by LVG were 49.1% in Group I, 41.7% in Group II and 49.2% in Group III. The difference in EF between Group I and Group III vs Group II was significant(p=0.008 in Group I, p=0.014 in Group III vs Group II). 3) Fatal bleeding complications(1 intracranial hemorrhage and 1 gastric ulcer bleeding) developed in Group II (Double dose). 4) Pain to door time, pain to needle time and door to needle time tended to be shorter in open(TIMI flow II-III) IRA group than in closed IRA group. 5) Initial EF were similar between open IRA group and closed IRA group(46.1% and 42.1% ; p=NS). The EF of open IRA group measured by LVG on initail coronary angiography(41.8% in closed IRA vs 48.0%, in open IRA, p=0.03) and by 2D-Echo on 7-10 day(41.7% in closed IRA vs 51.0% in open IRA, p=0.004) were better than those of closed IRA group. 6) Indirect clinical indices of reperfusion such as mean CPK peak, time to CPK peak significantly lower in open IRA group than in closed IRA group. 7) Fatal bleeding complications(1 intacranial hemorrhage and 1 gastric ulcer bleeding) developed in closed IRA group. CONCLUSION: The findings we observed in this trial showed that earlier initiation and more rapid infusion of UK were associated with more increased 90min patency of infarct-related artery and more improved LV function without any obviously increased bleeding complications or other serious life-threatening complications than conventional UK therapy. Specifically, double bolus IV injection of UK(1.5 million U bolus followed by 20,000 U/Kg bolus in 30min)was more effective method of thrombolysis than conventional method for achieving optimal reperfusion in AMI patients. Also, IRA patency at 90 minutes after the initiation of thrombolysis was important in preserving global LV function in early recovery phase of AMI. Further trials may be needed to determine more effective thrombolysis with UK in AMI.
Arteries
;
Body Weight
;
Consensus
;
Echocardiography
;
Female
;
Hemorrhage
;
Humans
;
Intracranial Hemorrhages
;
Korea
;
Myocardial Infarction*
;
Needles
;
Plasminogen
;
Prospective Studies
;
Reperfusion
;
Stomach Ulcer
;
Urokinase-Type Plasminogen Activator*
4.Effect of High-Dose Tamoxifen on Malignant Gliomas.
Yeon Chul OH ; Jung Hoon KIM ; Jung Kyo LEE ; Chang Jin KIM ; Yang KWON ; Seung Chul RHIM ; Byung Duck KWUN ; C Jin WHANG
Journal of Korean Neurosurgical Society 1996;25(9):1779-1785
In vitro studies have shown that the nonsteroidal antiestrogen tamoxifen can suppress deoxyribonucleic acid(DNA) synthesis and cell proliferation in cultured human gliomas. This growth suppression is independent on its antiestrogenic properties. Tamoxifen may act through the inhibition of the enzyme protein kinase C(PKC), which transduces mitogenic signals from the cell surface to the nucleus. In order to evaluate the therapeutic response and side effect of high-dose tamoxifen, we performed a clinical study of 28 patients with malignant gliomas who were treated with high-dose tamoxifen in our hospital between February 1991 and January 1993. An effect was defined as a statistically improved survival times/rates. In patients who were assigned to receive high-dose tamoxifen, it was first administered at standard antiestrogen doses(20mg orally bid/day) to observe for any side effect and if tolerated, the dose was increased weekly to achieve target doses(100mg orally bid/day) over a 1 month period. We compared the survival times/rates between anaplastic astrocytomas and glioblastoma mutiformes. Although the median survival time was slightly longer in anaplastic astrocytomas than that of glioblastoma multiformes, there was no statistical difference of survival curves between two groups at the p=0.05 level. We also examined the survival times/rates of malignant gliomas according to treatment modalities(radiotherapy alone, radiotherapy plus ACNU, and radiotherapy plus tamoxifen). Although the survival rate and time were slightly higher in radiotherapy plus tamoxifen group than those of another treatment groups, we could not find the statistical significance of survival curves between three treatment groups(p>0.05). High-dose oral tamoxifen appeared to be well tolerated in most patients. Five patients developed anorexia following dose escalation of tamoxifen. Another complications were amenorrhea, nausea/vomiting, and constipation. There were no changes in hematological studies that could be attributed to tamoxifen. We think that high-dose tamoxifen cah be administered safely to malignant gliomas patients. Our results were not impressive. We conclude that the definition of the true efficacy of high-dose tamoxifen in patients harboring malignant gliomas is not possible from this limited study, and a further large scale, randomized trial of this agent is necessary.
Amenorrhea
;
Anorexia
;
Astrocytoma
;
Cell Proliferation
;
Constipation
;
Estrogen Receptor Modulators
;
Female
;
Glioblastoma
;
Glioma*
;
Humans
;
Nimustine
;
Protein Kinase C
;
Protein Kinases
;
Radiotherapy
;
Survival Rate
;
Tamoxifen*
5.Cranial Chordoma ; Clinical Presentation and Multimodality Treatment.
Seok Kwan OH ; Jung Hoon KIM ; Young Shin RA ; Chang Jin KIM ; Yang KWON ; Seung Chul RHIM ; Jung Kyo LEE ; Byung Duk KWON ; C Jin WHANG
Journal of Korean Neurosurgical Society 1996;25(5):962-969
Cranial chordomas are rare and generally slow-growing malignant neoplasms of presumed notochordal origin. They seldom metastasize, but are difficult to manage because of their locally invasive nature and their proximity to critical structures. The clinical presentation and results of operative treatment, radiation therapy, and radiosurgery in a series of 10 patients with cranial chordomas seen at our hospital, between June 1989 and December 1994, are analysed. There were 4 men and 6 women with a mean age of 37.5 years. The most common presenting symptoms were visual loss, motor weakness and diplopia, and the most common presenting sign was visual field defect. The mean interval between symptom onset and initial treatment was 4.8(1-17) months. Three tumors classified as the chondroid type showed better clinical course. Extent of tumor resection included biopsy in 1 patient and subtotal or greater in 9. Four patients received postoperative radiation therapy and 4 patients stereotactic radiosurgery using Leksell gamma unit. Among them 1 patient showed tumor progression after radiation therapy but none after radiosurgery. One patient died due to tumor recurrence and two patients due to therapy but none after radiosurgery. One patient died due to tumor recurrence and two patients due to postoperative complications. At the time of analysis 7 patients were alive. The average length of follow-up for the alive patients was 34 months. The results of this study suggest that multimodality treatment using surgical debulking, radiation therapy and stereotactic radiosurgery is necessary for the optimal management of chordoma.
Biopsy
;
Chordoma*
;
Diplopia
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Notochord
;
Postoperative Complications
;
Radiosurgery
;
Recurrence
;
Visual Fields
6.Classification and Surgical Treatment of Paraclinoid Aneurysms.
Moon Jun SOHN ; Chae Heuck LEE ; Young Shin RA ; Chang Jin KIM ; Yang KWON ; Seung Chul RHIM ; Jung Kyo LEE ; Byung Duk KWUN ; C Jin WHANG
Journal of Korean Neurosurgical Society 1996;25(9):1828-1839
Paraclinoid aneurysms arose from the proximal internal carotid artery between the site of emergence of carotid artery from the roof of the cavernous sinus and posterior communicating artery. Surgery of these aneurysms presents special difficulties because of its complicated osseous, dura, and neurovascular structures;sella turcica, cavernous sinus, optic nerve. The clinical and radiological characteristics in twenty-seven patients with the paraclinoid aneurysms were reviewed and classified into four subgroups according to their branch of origin in this segment;1) carotid cave aneurysm(2 cases), 2) ophthalmic artery aneurysm(11 cases), 3) superior hypophyseal artery aneurysm(11 cases), 4) proximal posterior carotid artery wall aneurysm or global type aneurysm(3 cases). Surgery required orbital unroofing and removal of anterior clinid process with release of dural ring. To provide easy proximal control, exposure of cervical carotid artery was helpful in some cases. Preoperative balloon occlusion testing was man datory. Outcomes were considered as good to fair in 19 patients, poor in five, and three patients died. The patients who had poor results were poor preoperative status-four were grade IV, one was grade II(Hunt-Hess grade). The causes of death were premature rupture(2 cases) and extensive vasospasm(1 case). Preoperative classification of these lesions provides excellent correlation of operative findings and surgical preparation to expose the proximal part of internal carotid artery.
Aneurysm*
;
Arteries
;
Balloon Occlusion
;
Carotid Arteries
;
Carotid Artery, Internal
;
Cause of Death
;
Cavernous Sinus
;
Classification*
;
Humans
;
Ophthalmic Artery
;
Optic Nerve
;
Orbit
7.Surgical Treatment of Unstable Thoracic and Lumbar Spine Disease Using TSRH Instrumentation.
Moon Jun SOHN ; Ho Yun LEE ; Jung Hoon KIM ; Young Shin RA ; Yang KWON ; Seung Chul RHIM ; Jung Kyo LEE ; Byung Duk KWUN ; Choong Jin WHANG
Journal of Korean Neurosurgical Society 1996;25(8):1626-1632
The authors present surgical experience with 33 patients who had incurred unstable thoracic or lumbar spine pathology(22 degenerative lumbar spine disease, 6 trauma, 3 tumor, 2 vertebral tuberculosis) and who were intraoperatively stabilized with the Texas Scottish Rite-Hospital(TSRH) universal instrumentation system over 20 months period. The 11 men and 22 women(mean age 45 years, range 23 to 71 years) presenting with signs or symptoms of neural compression underwent surgery consisting of neural decompression, internal fixation, and bone grafting. Spondylolisthesis were fused in situ without reduction. For thoracic and thoracolumbar junction pathology, multisegment fixations were performed. A 95% fusion rate was obtained with a mean follow-up period of 15 months. There were no cases of instrumentation failure. Major postoperative complications included 2 isolated nerve root deficits(one transient, one permanent) and 3 pulmonary embolism(one fatal). The construct design of the TSRH system offers some advantag es compared to other forms of interal fixation:simple assembly, rigid stability, safety, and ability to remove easily. This system provides a highly successful method to obtain arthrodesis for unstable thoracic or lumbar spine.
Arthrodesis
;
Bone Transplantation
;
Decompression
;
Follow-Up Studies
;
Humans
;
Male
;
Pathology
;
Postoperative Complications
;
Spinal Fusion
;
Spine*
;
Spondylolisthesis
;
Texas
8.Surgical Management of Unruptured Intracranial Aneurysms.
Jong Han NAH ; Jung Hoon KIM ; Chang Jin KIM ; Yang KWON ; Seung Chul RHIM ; Jung Kyo LEE ; Byung Duck KWUN ; C Jin WHANG
Journal of Korean Neurosurgical Society 1996;25(3):593-601
With the ever- increasing number of intact aneurysms revealed by modern imaging, the options for their management are assuming greater importance. The surgical management of patients with unruptured intracranial aneurysms continues to be contoversial, and the criteria for withholding treatment or choosing between endovscular embolization and conventional microsurgery are not well delineated. In order to define the surgical result for unruptured intracranial aneurysms, 41 patients(from June 1989 to May 1995) with surgically treated unruptured aneurysms were analyzed. They were categorized as incidental, multiple or aneurysm with mass effect. Subarachnoid hemorrhage from another aneurysm(multiple) was the most common presentation(19 patients). Eleven patients were presented with incidental findings unrelated to aneurysmal subarachnoid hemorrhage or direct aneurysmal mass effect, and 11 patients were presented with mass effect such as cranial nerve palsy or brain stem compression. We could perform direct neck clipping presented with mass effect such as cranial nerve palsy or brain stem compression. We could perform direct neck clipping with without wrapping in 37 patients, trapping in 2, and wrapping in 1. One patient with giant vertebrobasilar artery aneurysm(greater than 25mm in diameter) which was presented with mass effect could not be treated adequately. Instances of morbidity included cranial nerve injury in 4 patients, hemiparesis in 3, hematoma in 2, and major hemispheric infarction in 1. One patient presented with mass effect, died from major hemispheric infarction after surgery of proximal internal carotid artery aneurysm with a size greater than 25mm in diameter. Two patients, who underwent surgery for giant vertebrobasilar artery aneurysms presented with mass effect, were in poor state due to persistent cranial nerve palsy and homiparesis. In general overall outcome was very good. Excellent or good outcome was achieved in 38 patients(92.7%) while 3 patients(7.3%) either died or was/were in poor condition. The aneurysm size was correlated well with the surgical outcome. We have achieved excellent or good out comes in 100% of patients with aneurysms 25mm or less in diameter. However, with aneurysms greater than 25mm in diameter, the outcomes were very poor with 75% of these patients in poor state or dead. "Surgery in unruptured aneurysms?" The answer was "Yes". We believe the size and location of the aneurysm are the key predictons of risk for sugical morbidity.
Aneurysm
;
Arteries
;
Brain Stem
;
Carotid Artery, Internal
;
Cranial Nerve Diseases
;
Cranial Nerve Injuries
;
Hematoma
;
Humans
;
Incidental Findings
;
Infarction
;
Intracranial Aneurysm*
;
Microsurgery
;
Neck
;
Paresis
;
Subarachnoid Hemorrhage
;
Withholding Treatment
9.Clinical Analysis of the CNS Malignant Lymphomas.
Jae Sung AHN ; Chang Jin KIM ; Yang KWON ; Seung Chul RHIM ; Jung Kyo LEE ; Byung Duk KWUN ; Choong Jin WHANG
Journal of Korean Neurosurgical Society 1995;24(5):546-554
Malignant CNS lymphoma is a malignant intracranial tumor and in most cases they run a fulminating course if left untreated, with 3 to 5 months survival after appearance of the initial symptoms. Sixteen patients with malignant lymphoma were treated in Asan Medical Center from 1989 to 1994. All patients were underwent tissue diagnosis with subtotal resection or stereotactic biopsy and followed by cranial or craniospinal irradiation with or without systemic chemotherapy. One and three year survival rate of the patients was 88% and 78% respectively. In conclusion, addition of chemotherapy and/or cranial radiation for treatment of the CNS lymphoma may improve survival.
Biopsy
;
Chungcheongnam-do
;
Craniospinal Irradiation
;
Diagnosis
;
Drug Therapy
;
Humans
;
Lymphoma*
;
Survival Rate
10.Surgical Mangagement of Brainstem Hematoma Caused by Angiographically Occult Vascular Malformation(AOVM).
Jae Sung AHN ; Chang Jin KIM ; Yang KWON ; Seung Chul RHIM ; Jung Kyo LEE ; Byung Duk KWUN ; C Jin WHANG
Journal of Korean Neurosurgical Society 1995;24(1):79-83
Brain stem hematomas, expecially due to ruptured angiographically occult vascular malformation(AOVM), are of great interest because they are potentially curable. Preoperative diagnosis has been difficult due to poor resolution of CT scans in the posterior fossa region. The advent of MRI has made the identification of the angiographically occult vascular malformation possible before surgical excision. We preset 3 cases of brainstem hematoma due to vascular malformations which wre not visualized by angiography but were diagnosted by MRI. The patients were treated surgically and vascular malformations were confirmed.
Angiography
;
Brain Stem*
;
Diagnosis
;
Hematoma*
;
Humans
;
Magnetic Resonance Imaging
;
Tomography, X-Ray Computed
;
Vascular Malformations

Result Analysis
Print
Save
E-mail